Leukemia's Next Top Model? Syngeneic Models to Advance Adoptive Cellular Therapy.
Zoine JT, Moore SE, Velasquez MP.
Front Immunol. 2022 Mar 25;13:867103. doi: 10.3389/fimmu.2022.867103. eCollection 2022.
Multiparameter flow cytometry in the diagnosis and management of acute leukemia.
Peters JM, Ansari MQ.
Arch Pathol Lab Med. 2011 Jan;135(1):44-54. doi: 10.5858/2010-0387-RAR.1.
Chronic lymphocytic leukaemia.
Scarfò L, Ferreri AJ, Ghia P.
Crit Rev Oncol Hematol. 2016 Aug;104:169-82. doi: 10.1016/j.critrevonc.2016.06.003. Epub 2016 Jun 16.
The molecular and clinical significance of the Tie/angiopoietin system in leukemia.
Vedadi S, Azimzadeh M, Touluei AE, Rahimpour S, Shotorbani SS.
Pathol Res Pract. 2023 Feb;242:154285. doi: 10.1016/j.prp.2022.154285. Epub 2022 Dec 17.
Type I interferons: leukemia's old foe in the limelight again.
Kumar A, Swaminathan S.
Haematologica. 2024 Jul 1;109(7):2026-2028. doi: 10.3324/haematol.2024.285079.
Revumenib: First Approval.
Syed YY.
Drugs. 2025 Apr;85(4):577-583. doi: 10.1007/s40265-025-02161-5.
Adipocytes in hematopoiesis and acute leukemia: friends, enemies, or innocent bystanders?
Zinngrebe J, Debatin KM, Fischer-Posovszky P.
Leukemia. 2020 Sep;34(9):2305-2316. doi: 10.1038/s41375-020-0886-x. Epub 2020 May 30.
Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C.
Br J Haematol. 1976 Aug;33(4):451-8. doi: 10.1111/j.1365-2141.1976.tb03563.x.
Advances in germline predisposition to acute leukaemias and myeloid neoplasms.
Klco JM, Mullighan CG.
Nat Rev Cancer. 2021 Feb;21(2):122-137. doi: 10.1038/s41568-020-00315-z. Epub 2020 Dec 16.
Targeting leukemia's "fatty tooth".
Samudio I, Konopleva M.
Blood. 2015 Oct 15;126(16):1874-5. doi: 10.1182/blood-2015-08-665125.
